Production-Grade Biocomputational Systems
Engineered for biotech innovators, global pharmaceutical leaders, and institutional researchers. Deploy individual modules or license the complete Ultraceuticals OS.
Dossier360™
Autonomous Multi-Agent Regulatory & Freedom-to-Operate Intelligence
Modern biopharmaceutical due diligence requires algorithmically deterministic triaging across Intellectual Property (IP) & Freedom-to-Operate (FTO), Bioequivalence (BE), and Therapeutic Interchangeability. Dossier360 deploys specialized autonomous agent swarms that parse Hatch-Waxman patent thickets, BPCIA 351(k) biosimilar pathways, Orange and Purple Book listings, and ICH Q6A specifications.
Engine Benchmarks
BioDesign Studio™
Unified Small Molecule & Biologics Generative Engineering
BioDesign Studio bridges small molecule medicinal chemistry and complex macromolecular biologics. Whether synthesizing novel kinase allosteric inhibitors, macrocyclic peptides, or humanized monoclonal antibodies (mAbs), the system applies deep structural diffusion models to optimize affinity, developability, and target selectivity.
Engine Benchmarks
FoldPredict™
Sub-Angstrom Protein & Macromolecular Complex Modeling
Proteins are dynamic conformational ensembles, not static crystal snapshots. FoldPredict predicts multi-state protein conformations, quaternary protein-protein interactions (PPI), and cryptic allosteric pockets with sub-angstrom root-mean-square deviation (RMSD).
Engine Benchmarks
DynaDock™ MD & FEP
High-Precision GPU Molecular Dynamics & Free Energy Perturbation
DynaDock pairs microsecond-scale GPU all-atom molecular dynamics with rigorous Free Energy Perturbation (FEP+) and QM/MM induced-fit docking. It precisely quantifies thermodynamic binding free energy (ΔG), entropic penalties, and water-mediated hydrogen bonding networks.
Engine Benchmarks
SpectraRank™ ADMET
High-Fidelity Pharmacokinetics & Blood-Brain Barrier Penetration
SpectraRank combines deep graph neural networks and molecular mechanics to evaluate drug-likeness, blood-brain barrier permeability, and cardiotoxicity risks. It accurately computes log BB ratios, P-glycoprotein efflux pump liabilities, and hERG safety margins before animal in vivo testing.

